News

Foley Hoag Joins COVID Relief Coalition for Small Businesses and Nonprofits

April 13, 2020

Foley Hoag LLP has joined with several Massachusetts law firms, legal services organizations, and government agencies to launch the COVID Relief Coalition for Small Businesses and Nonprofits.

By providing pro bono legal support, the COVID Relief Coalition will help vulnerable small businesses and mission-driven organizations overcome the challenges they are facing as a result of the COVID-19 pandemic.

The Coalition also recently announced the launch of a new website that will support its mission by enabling small businesses and nonprofits to learn about and apply for emergency loans and other sources of relief. The website will connect eligible small businesses and nonprofits to free legal support by Coalition partners who will be able to assist with questions on pandemic-related issues including real estate, tax and contractual matters.

In addition to Foley Hoag, Coalition partners include Ropes & Gray (Coalition leader, with Lawyers for Civil Rights and Lawyers Clearinghouse), Fish & Richardson, Foley & Lardner, Goodwin, Goulston & Storrs, Mintz, Morgan Lewis , WilmerHale and Dechert, as well as the Massachusetts Attorney General’s Office, City of Boston, Greater Boston Chamber of Commerce, Boston Bar Association, The Boston Foundation and United Way of Massachusetts Bay and Merrimack Valley.

"Foley Hoag is proud to stand alongside fellow Massachusetts law firms, government agencies and legal services organizations in an effort to provide much-needed pro bono assistance to the state's many small businesses and nonprofits that have been affected by the COVID-19 pandemic," said Foley Hoag Pro Bono Managing Attorney Rebecca Cazabon. "These businesses have been vital to the economy and growth of many communities in Massachusetts, and we are eager to be of assistance to them."

On March 13, 2020, Foley Hoag announced the formation of a firm-wide, multi-disciplinary task force dedicated to client matters related to COVID-19, during the pandemic and beyond.